FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

716015005: Necitumumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2016. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3304441018 Necitumumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3304442013 Necitumumab en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Necitumumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Necitumumab Is a Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier
Necitumumab Is a Chemical categorized functionally false Inferred relationship Existential restriction modifier
Necitumumab Has disposition Epidermal growth factor receptor inhibitor true Inferred relationship Existential restriction modifier
Necitumumab Is a Enzyme inhibitor protein true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing necitumumab (medicinal product) Has active ingredient True Necitumumab Inferred relationship Existential restriction modifier 1
Product containing necitumumab in parenteral dose form (medicinal product form) Has active ingredient True Necitumumab Inferred relationship Existential restriction modifier 1
Product containing only necitumumab in parenteral dose form (medicinal product form) Has active ingredient True Necitumumab Inferred relationship Existential restriction modifier 1
Necitumumab Has active ingredient True Necitumumab Inferred relationship Existential restriction modifier 1
Product containing precisely necitumumab 16 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Necitumumab Inferred relationship Existential restriction modifier 1
Product containing precisely necitumumab 16 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Necitumumab Inferred relationship Existential restriction modifier 1
Portrazza 800mg/50ml concentrate for solution for infusion vials (Originalis B.V.) 1 vial Has specific active ingredient True Necitumumab Inferred relationship Existential restriction modifier
Portrazza 800mg/50ml concentrate for solution for infusion vials (Originalis B.V.) Has specific active ingredient True Necitumumab Inferred relationship Existential restriction modifier
Necitumumab 800mg/50ml solution for infusion vials Has specific active ingredient True Necitumumab Inferred relationship Existential restriction modifier
Necitumumab 800mg/50ml solution for infusion vials 1 vial Has specific active ingredient True Necitumumab Inferred relationship Existential restriction modifier
Portrazza 800mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) Has specific active ingredient False Necitumumab Inferred relationship Existential restriction modifier
Portrazza 800mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial Has specific active ingredient False Necitumumab Inferred relationship Existential restriction modifier
Portrazza 800mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) Has specific active ingredient True Necitumumab Inferred relationship Existential restriction modifier
Portrazza 800mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial Has specific active ingredient True Necitumumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start